The 20 Best Prostate Cancer Doctors Near Me in Denton, TX

My goals are to develop and provide treatments that prolong and improve quality of the lives of patients with aggressive prostate, kidney, bladder, and testicular cancer. This work involves the direct care of patients in the clinic and clinical research involving the development of new therapies in clinical trials. I devote over half of my time to understanding how prostate cancer spreads and resists therapies, as well as methods of measuring this biology in patients, which may lead to improved therapies designed to block this process. Outside of work, I have a busy family life with three children, and a wife who is a Duke pediatrician. I enjoy playing soccer and hiking. Dr. Armstrong is rated as an Elite provider by MediFind in the treatment of Prostate Cancer. He is also highly rated in 17 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Familial Prostate Cancer, Renal Cell Carcinoma (RCC), Orchiectomy, and Prostatectomy. Dr. Armstrong is board certified in American Board Of Internal Med, Internal Medicine and American Board Of Internal Med, Medical Oncology.

I specialize in the care of patients with urologic cancers – mainly prostate cancer, kidney cancer, bladder cancer and testicular cancer. A cancer diagnosis is one of the scariest things that can happen to someone. For many of our patients, they don’t necessarily feel different or look different, but they are scared to death. The most important thing you can get from Duke is real understanding of your particular case and what your options are. Knowledge is so reassuring and empowering for patients, especially those recently diagnosed with cancer. When you’re first diagnosed, you have to put your trust in a care team, and that’s hard to do if you don’t already know them. As the largest cancer center in North Carolina, Duke has great reputation and experience, which helps many patients chose Duke for their care. But we grow and develop our trust with patients because of who we are as people and how much expertise and care we bring to each case. Dr. George is rated as an Elite provider by MediFind in the treatment of Prostate Cancer. He is also highly rated in 17 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Renal Cell Carcinoma (RCC), Familial Prostate Cancer, Nephrectomy, and Orchiectomy.

Dr. Michael A. Carducci is the AEGON Professor in Prostate Cancer Research at the Johns Hopkins University School of Medicine. He serves as the Vice Chair of Solid Tumor Oncology in the Department of Oncology. Dr. Carducci has an expertise in various types of cancer including prostate, kidney, and testicular. He also has an expertise in clinical trials, pain and palliative care for oncology, urological oncology, urology and medical oncology. A graduate of Georgetown University, Dr. Carducci received his medical degree with high distinction from Wayne State University School of Medicine. He completed an internal medicine internship, residency and chief residency at the University of Colorado Health Sciences Center. He went on to complete medical oncology and research fellowships at the Johns Hopkins Oncology Center at Johns Hopkins Hospital. He was promoted to Professor of Oncology and Urology in 2008 and installed into the inaugural AEGON Professorship in Prostate Cancer Research in 2009. He served as Co-Director of the GU Oncology program until 2013. In 2013, he assumed the leadership role of Associate Director for Clinical Research until being named Vice-Chair of Solid Tumor Oncology in 2024. A fellow of the American College of Physicians and a fellow of the American Society of Clinical Oncology, Dr. Carducci has received peer-reviewed funding for his clinical research from the National Cancer Institute, Department of Defense, and the Prostate Cancer Foundation. Mentorship of students, fellows, and junior faculty has been another focus of Dr. Carducci’s career in medicine, receiving numerous teaching awards. Dr. Carducci received the Michaele Christian Award and Lectureship for Oncology Drug Development at the National Cancer Institute in 2011. He chaired the Genitourinary Oncology Committee of ECOG-ACRIN from 2011-2024. In this role, he served on the GU Steering Committee for the NCI. Dr. Carducci is a member of the Investigational Drug Steering Committee for the NCI, and chaired that Committee for four years. He served as Associate Editor for GU Cancers for the Journal of Clinical Oncology from 2013-2024. Overall, his clinical research focus is on the development and evaluation of new therapies for urologic cancers. Incorporation of pharmacodynamics, novel biomarkers, and targeted imaging has been key elements of many of the trials led by Dr. Carducci. To complete these studies, Dr. Carducci facilitates and brings together a multidisciplinary team from urologists, radiation oncologists, pathologists, biostatisticians, and medical oncologists. Other areas of interest include palliative and end of life care, survivorship, and use of patient reported outcomes in clinical research and care. This provider is registered with the Florida Department of Health to perform telehealth services for patients in Florida. Dr. Carducci is rated as an Elite provider by MediFind in the treatment of Prostate Cancer. He is also highly rated in 16 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Chromophobe Renal Cell Carcinoma, Renal Cell Carcinoma (RCC), Hormone Replacement Therapy (HRT), and Prostatectomy. Dr. Carducci is board certified in American Board Of Internal Medicine.

As Senior Vice President of the Urology Service Line, Chair of theSmith Institute for Urology, and Chair of Urology at the Zucker Schoolof Medicine at Hofstra/Northwell, Samir Taneja, MD will establish hisclinical practice at Lenox Hill Hospital and Long Island Jewish MedicalCenter focused on the surgical management of prostate cancerand renal tumors. He is an expert in urologic oncology, renowned fortransforming the field of prostate cancer diagnosis and treatmentby improving methods of prostate imaging, cancer detection, anddisease localization. Having performed thousands of robotic, ablative,laparoscopic and open surgical procedures, his specific clinical focushas been in improving prostate cancer patient outcomes throughpioneering techniques for focal ablative therapy, refining surgicaltechniques for robotic prostatectomy and partial nephrectomy,devising accelerated recovery pathways for robotic prostatectomy/partial nephrectomy, and providing muti-modal surgical approachesfor patients with high risk and recurrent prostate cancer. As leader ofthe department, he will strive to ensure individualized care of urologicdisease through state-of-the-art surgical approaches and multi-disciplinary care.Prior to joining Northwell, Dr Taneja was a faculty member of NYUGrossman School of Medicine for 29-years as a tenured professorof urology, radiology, and biomedical engineering. Most recently heserved as Director of the Division of Urologic Oncology and ViceChair in the Department of Urology at NYU Langone Health, as well asGenitourinary Program Leader in the Perlmutter Cancer Center.Dr. Taneja has conducted extensive clinical research on the use ofimaging in prostate cancer and is considered a pioneer in the use ofMRI to diagnose and localize prostate cancer and the emerging field ofprostate cancer focal therapy. He has authored more than 250 articles,30 book chapters, and six textbooks and monographs on urologiccancer and surgery. He is the editor of Taneja's Complications ofUrologic Surgery: Prevention and Diagnosis, one of the most widely readtextbooks in American Urology. Dr. Taneja is rated as an Elite provider by MediFind in the treatment of Prostate Cancer. He is also highly rated in 19 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Familial Prostate Cancer, Renal Cell Carcinoma (RCC), Prostatectomy, and Nephrectomy. Dr. Taneja is board certified in American Board Of Urology.

Brian T. Helfand, MD, a urologist at Endeavor Health, specializes in urologic oncology and the treatment of prostate conditions. His clinical expertise includes minimally invasive surgery, advanced laparoscopy and procedures using the da Vinci robotic system. Dr. Helfand treats conditions such as benign prostatic hyperplasia, prostate cancer and urinary dysfunction using personalized and evidence-based approaches. Dr. Helfand is rated as an Elite provider by MediFind in the treatment of Prostate Cancer. He is also highly rated in 37 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Familial Prostate Cancer, Enlarged Prostate (BPH), Aquablation, and Prostatectomy. Dr. Helfand is board certified in American Board Of Urology.

Edward Schaeffer is an Oncologist practicing medicine in Chicago, Illinois. He has been practicing medicine for over 25 years. Dr. Schaeffer is rated as an Elite provider by MediFind in the treatment of Prostate Cancer. He is also highly rated in 5 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Familial Prostate Cancer, Bladder Cancer, Prostatectomy, and Ureteroscopy. Dr. Schaeffer is board certified in American Board Of Urology - Urology (Certified).

I have a passion for caring for men with prostate cancer and helping them and their families make the best treatment decisions. I am nationally and internationally recognized as a prostate cancer expert and have performed more than 2,000 radical prostatectomies both at Duke and formerly at Walter Reed Army Medical Center. I specialize in the nerve-sparing technique of surgery affording the best chance for sexual recovery. I have more experience with this small incisional open hands-on nerve-sparing operation than any surgeon in the Southeastern United States and am among the 10 most experienced surgeons using this technique in the United States. In addition to surgery, I have extensive experience managing men who have an elevated PSA and perform a gentle prostate biopsy using very liberal doses of local anesthesia. Our team also offers management of men who elect active surveillance for their early stage prostate cancer and are sensitive to men's needs regarding management of temporary urinary and sexual dysfunction related to prostate cancer treatments. We have a very experienced nursing team and a very experienced physician assistant who greatly assists in comprehensive and compassionate care. Dr. Moul is rated as an Elite provider by MediFind in the treatment of Prostate Cancer. He is also highly rated in 6 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Familial Prostate Cancer, Enlarged Prostate (BPH), Prostatectomy, and Orchiectomy. Dr. Moul is board certified in American Board Of Urology, Urology.

Dr. Channing J. Paller is a medical oncologist at Sibley Memorial Hospital and a professor of oncology at the Johns Hopkins University School of Medicine. She practices out of the Prostate Cancer Multidisciplinary Clinic at Sibley Memorial Hospital in Washington, D.C., and the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins in Baltimore, MD. Dr. Paller has expertise in prostate, bladder, kidney, and testicular cancer. Dr. Paller earned her medical degree from Harvard Medical School and completed a residency in internal medicine, followed by a fellowship in hematology and oncology at Johns Hopkins University School of Medicine. In addition, Dr. Paller completed a rotation with the chief of the Investigational Drug Branch at the National Cancer Institute (NCI) Cancer Therapy Evaluation Program and a rotation with the associate director for regulatory science in the Office of Oncology Drug Products at the Food and Drug Administration. She also completed rotations at the Weizmann Institute of Israel’s Department of Biological Regulation and McCord Hospital in South Africa, where she participated in the Harvard AIDS project. In 2016, Dr. Paller was one of only five oncologists awarded the NCI Mentored Patient-Oriented Research Career Development Award. In 2015, she received the 2015 Passano Clinician Scientist Award for early-stage research that is already making a contribution to science. Earlier in her career, she was selected for both a 2011-2012 Young Investigator Award by the American Society of Clinical Oncology and for the 2011-12 Eastern Cooperative Oncology Group Paul Carbone Award. Dr. Paller is a member of the American Society of Clinical Oncology and the American Association for Cancer Research. Dr. Paller’s research focuses on evaluating new therapies for prostate cancer, particularly combination therapies that engage the immune system. She is the principal investigator on two multi-site clinical trials and was the first author on the NCI Investigational Drug Steering Committee publication, “Consensus Recommendations on the Phase I Combination Clinical Trials of the Clinical Trial Design Task Force.” Dr. Paller was the chair for the oral abstract session on genitourinary cancer at the 2015 Annual Meeting of the American Society of Clinical Oncology and she is currently funded by an NCI immunotherapy grant to look at combination therapies that link standard of care therapy with inhibition of transforming growth factor beta in prostate cancer. She is also opening trials of vitamin C with chemotherapy in prostate cancer and of mistletoe in all solid tumors. Dr. Paller is rated as an Elite provider by MediFind in the treatment of Prostate Cancer. She is also highly rated in 7 other conditions, according to our data. Her clinical expertise encompasses Prostate Cancer, Familial Prostate Cancer, Muscle Invasive Bladder Cancer, Hormone Replacement Therapy (HRT), and Prostatectomy. Dr. Paller is board certified in American Board Of Internal Medicine.

William Catalona is a Urologist practicing medicine in Chicago, Illinois. He has been practicing medicine for over 58 years. Dr. Catalona is rated as an Elite provider by MediFind in the treatment of Prostate Cancer. He is also highly rated in 4 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Familial Prostate Cancer, Bacterial Prostatitis, Prostatectomy, and Vasectomy. Dr. Catalona is board certified in American Board Of Urology - Urology (Certified).

Every day, my goal is to take the best surgical care of my patients' kidney or prostate cancer by offering the most up-to-date minimally invasive surgical treatments, while making sure that their experiences and outcomes at Duke Health are top-notch! As we look at the scans together and discuss biopsy results, it is important to me that I spend all of the time that my patients and their families need to clearly understand their diagnosis as well as all treatment options, so that we can make joint decisions about next steps and their treatment plan. Many of my patients are referred from all over the country to seek highly specialized urology care, including nonsurgical focal cryotherapy for prostate cancer, robotic surgery for prostate cancer, or robotic surgical removal of their kidney tumor called a partial nephrectomy, among other treatments, with our multidisciplinary, collaborative team. I always reassure and share my positive outlook with my patients as we navigate the health system together. My patients know that, as their physician, I will be their champion and advise them and guide them through their treatment. We are in this together. Dr. Polascik is rated as an Elite provider by MediFind in the treatment of Prostate Cancer. He is also highly rated in 21 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Familial Prostate Cancer, Renal Cell Carcinoma (RCC), Prostatectomy, and Nephrectomy. Dr. Polascik is board certified in American Board Of Urology, Urology.

Leonard Gomella is an Oncologist and a General Surgeon practicing medicine in Philadelphia, Pennsylvania. Dr. Gomella is rated as an Elite provider by MediFind in the treatment of Prostate Cancer. He is also highly rated in 10 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Bladder Cancer, Familial Prostate Cancer, Prostatectomy, and Cystectomy. Dr. Gomella is board certified in Urology. Dr. Gomella is currently accepting new patients.

Robert Den is an Oncologist and a Radiation Oncologist practicing medicine in Philadelphia, Pennsylvania. Dr. Den is rated as an Elite provider by MediFind in the treatment of Prostate Cancer. He is also highly rated in 5 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Familial Prostate Cancer, Muscle Invasive Bladder Cancer, Retinoblastoma, and Prostatectomy. Dr. Den is board certified in Radiology and Radiation Oncology. Dr. Den is currently accepting new patients.

Dr. Kenneth Pienta is the Donald S. Coffey Professor of Urology and a professor of oncology at the Johns Hopkins School of Medicine. He also holds an appointment in the department of pharmacology and molecular sciences. He is an internationally recognized leader in prostate cancer research and translational science. Dr. Pienta serves as the director of research for the Brady Urological Institute and co-leader of the Kimmel Cancer Center's Prostate Cancer Program. Dr. Pienta has a proven, peer-reviewed track record in organizing and administering a translational research program that successfully incorporates bench research, agent development and clinical application. He has international expertise in the development of novel chemotherapeutic programs for prostate cancer and has championed the concept that translational research is often best accomplished by multi-disciplinary teams of scientists and clinicians. Under his direction, the success of these endeavors led to the receipt of the first annual American Association for Cancer Research Team Science Award in 2007. Dr. Pienta received his B.A. in human biology from the Johns Hopkins University. He earned his M.D. from the Johns Hopkins School of Medicine. He completed his residency at the University of Chicago Hospitals and Clinics and performed a fellowship in oncology at The Johns Hopkins Hospital. Prior to joining Johns Hopkins, Dr. Pienta was the associate vice president for research, health sciences for the University of the Michigan from 2012 to 2013 and director of precision medicine for the Michigan Center for Translational Pathology from 2008 to 2013. He joined the Johns Hopkins faculty in 2013. Dr. Pienta's research interests include the ecology of cancer, tumor microenvironment, metastasis, biomarker development and novel therapeutic development. Dr. Pienta is a two-time American Cancer Society Clinical Research Professor Award recipient. He holds several patents, has authored more than 350 peer-reviewed articles and has been the principle investigator on numerous local and national clinical trials. Dr. Pienta is currently actively developing clinical trials and treating patients with newly diagnosed high risk and metastatic prostate cancer. Dr. Pienta is rated as an Elite provider by MediFind in the treatment of Prostate Cancer. He is also highly rated in 6 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Bone Tumor, Familial Prostate Cancer, Prostatectomy, and Orchiectomy. Dr. Pienta is board certified in American Board Of Internal Medicine.

Edouard Trabulsi is an Oncologist practicing medicine in Philadelphia, Pennsylvania. Dr. Trabulsi is rated as an Elite provider by MediFind in the treatment of Prostate Cancer. He is also highly rated in 20 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Bladder Cancer, Muscle Invasive Bladder Cancer, Prostatectomy, and Nephrectomy. Dr. Trabulsi is board certified in Urology. Dr. Trabulsi is currently accepting new patients.

Ashesh Jani is a Radiation Oncologist practicing medicine in Atlanta, Georgia. He has been practicing medicine for over 31 years. Dr. Jani is rated as an Elite provider by MediFind in the treatment of Prostate Cancer. He is also highly rated in 6 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Muscle Invasive Bladder Cancer, Familial Prostate Cancer, Upper Tract Urothelial Carcinoma (UTUC), and Prostatectomy. Dr. Jani is board certified in American Board Of Radiology, 2001.

Dr. Christian Pavlovich is Bernard L. Schwartz Distinguished Professor in Urologic Oncology at the Johns Hopkins University School of Medicine and Director of the Prostate Cancer Active Surveillance Program at the Brady Urological Institute. Dr. Pavlovich treats cancer with an emphasis on minimizing morbidity and maximizing quality of life while offering patients the latest treatment options and techniques. His clinical focus is on prostate and kidney cancer, and on clinical trials regarding detection, surveillance, and immunotherapy. With more than 20 years of experience with minimally-invasive surgery for the treatment of urologic cancers, he is expert in robotic surgery and was named one of the top prostate cancer surgeons in the United States by Newsweek in 2024. In addition, he offers patients modern diagnostic biopsy techniques, and for prostate cancer patients active surveillance and ablative options including cryotherapy and TULSA. Dr. Pavlovich grew up in Washington DC, went to Harvard University, and then earned his medical degree at the University of California, San Francisco (UCSF) School of Medicine. He then completed a urology residency at New York Hospital-Cornell Medical Center and a National Cancer Institute SUO fellowship in urologic oncology before joining the Hopkins faculty in 2001. Dr. Pavlovich has published over 150 peer-reviewed articles, is Associate Editor of The Prostate and is on the Editorial Board of the British Journal of Urology International. He was the inaugural Director of the Brady Urological Institute’s SUO Urologic Oncology Fellowship (2014 -2024) and is the recipient of three “best teaching/research mentor” awards from the Urology residents at Johns Hopkins. Dr. Pavlovich speaks English, French, Spanish, German, and Serbo-Croatian. He enjoys spending time with his wife and children, following their pursuits, and skiing, diving, running, wildlife, and the great outdoors. Dr. Pavlovich is rated as an Elite provider by MediFind in the treatment of Prostate Cancer. He is also highly rated in 7 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Familial Prostate Cancer, Renal Cell Carcinoma (RCC), Prostatectomy, and Nephrectomy. Dr. Pavlovich is board certified in American Board Of Urology.

Arvin K. George, MD, is a urologic surgeon specializing in the diagnosis and management of genitourinary cancers, with particular sub-specialization in kidney and prostate cancers. His clinical interests and expertise are in image-guided therapeutics, and minimally-invasive ablative/surgical techniques for prostate and kidney cancer. These include laparoscopic and robotic surgery, in addition to cryoablation, high-intensity focused ultrasound ablation, nanoparticle directed laser ablation, laser interstitial thermal therapy, and bipolar radiofrequency ablation. Dr. George obtained his medical degree from the Royal College of Surgeons in Ireland, followed by a urology residency at the Smith Institute for Urology, Hofstra North Shore-LIJ School of Medicine. He remained to complete his endourology/minimally-invasive and robotic surgery fellowship in New York gaining additional subspecialty expertise in robotic, laparoscopic, and percutaneous surgery. Subsequently, he completed a urologic oncology fellowship at the National Cancer Institute, National Institutes of Health. He then joined the clinical facility at the University of Michigan, Ann Arbor, where he directed the Prostate Cancer Programs from 2019 through 2023. Dr. George participates extensively in the discovery of urologic science and evaluation of urologic care and has co-authored over 80 peer reviewed publications. Additionally, he has authored 11 chapters in medical education books. Dr. George sees patients in clinic throughout the Baltimore region and also is available for virtual appointments for patients in Maryland, Washington D.C., New York and Michigan. Dr. George is rated as an Elite provider by MediFind in the treatment of Prostate Cancer. He is also highly rated in 10 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Renal Cell Carcinoma (RCC), Familial Prostate Cancer, Prostatectomy, and Nephrectomy. Dr. George is board certified in American Board Of Urology.

Adam Dicker is an Oncologist and a Radiation Oncologist practicing medicine in Philadelphia, Pennsylvania. Dr. Dicker is rated as an Elite provider by MediFind in the treatment of Prostate Cancer. He is also highly rated in 12 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Familial Prostate Cancer, Gliomatosis Cerebri, Metastatic Brain Tumor, and Prostatectomy. Dr. Dicker is board certified in Radiology and Radiation Oncology. Dr. Dicker is currently accepting new patients.

Quoc-Dien Trinh, MD, MBA, serves as the Chair of the Department of Urology, University of Pittsburgh School of Medicine, and Chair of Urology, UPMC. A globally recognized urological surgeon-scientist, Dr. Trinh has been honored with the 2021 Outstanding Citizenship Award from Brigham and Women’s Hospital and the 2022 American Urological Association Young Urologist of the Year award for New England. He is recognized as a Castle Connolly Top Doctor and a Top Asian American Pacific Islander Doctor. Dr. Trinh is rated as an Elite provider by MediFind in the treatment of Prostate Cancer. He is also highly rated in 20 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Bladder Cancer, Familial Prostate Cancer, Prostatectomy, and Cystectomy. Dr. Trinh is board certified in American Board Of Urology. Dr. Trinh is currently accepting new patients.

Martin Sanda is a Urologist practicing medicine in Atlanta, Georgia. He has been practicing medicine for over 39 years. Dr. Sanda is rated as an Elite provider by MediFind in the treatment of Prostate Cancer. He is also highly rated in 5 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Familial Prostate Cancer, Urinary Incontinence, Prostatectomy, and Vasectomy. Dr. Sanda is board certified in American Board Of Urology, 1997.